Latest News

Australian government funds $1M for development of Covax-19® vaccine (MTPConnect)

The pioneering team at Vaxine who developed the world’s first swine flu vaccine in 2009, has been awarded funding of $1 million dollars from the Biomedical Translation Bridge (BTB) program, an initiative of the Medical Research Future Fund operated by MTPConnect, to help advance Vaxine’s state-of-the-art COVID-19 vaccine candidate called Covax-19®. Sharen Pringle, Vaxine’s Business […]

Computer models for potential COVID-19 treatments

“Thanks to our unique ability to run computer simulations on the virus before it is even fully characterised, we were able to dramatically speed up the ability to design our Covax-19® vaccine,” says Flinders University Professor Nikolai Petrovsky, Research Director of Vaxine. The Vaxine research team used this computer modelling on the virus spike protein […]

The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide

17 Developers Are Testing Coronavirus Vaccines on Humans. Here’s What You Need to Know About Them   Country: Australia Trial stage: Phase I The first Australian-developed candidate to reach human trials, Vaxine began a Phase I trial in early July in Adelaide. The trial will test 40 healthy candidates and results are expected in six to […]